T20211222001

IP属地:未知
    • T20211222001T20211222001
      ·2021-12-24
      $Walt Disney(DIS)$ Disneyland Parks face some serious issues if COVID surges into 2022. There is a lot of risk for Disney stock in early 2022. Streaming is not expected to regain growth until the 2nd half of 2022. Spiderman does not even benefit Disney profits either since it's a SONY film.
      887评论
      举报
    • T20211222001T20211222001
      ·2021-12-24
      $AMC Entertainment(AMC)$ Shorts are screwed and they know it! Kenny G hasn't delivered anything on time, especially FTDs. So why would he deliver the MOASS on time? Patience!
      1,010评论
      举报
    • T20211222001T20211222001
      ·2021-12-23
      $BiondVax Pharmaceuticals(BVXV)$ Can expect next catalysts, including, but not limited to :1. EIB extend repayment of previous loanOf 24 Mil.2. EIB giving another free interests loan ofXX mil.3. private placement from AngelInvestment.4. Grants from Israeli government, possibleFrom Germany as well.5. Buy out from majors.6. ETC….Sp will up 50-100% upon each announcement!Hold on tight and add if funds are available!GLTACheers!
      1,498评论
      举报
    • T20211222001T20211222001
      ·2021-12-22

      keep your seatbelt

      $Cassava Sciences Inc(SAVA)$ Likely big pharma is behind this short attack .. which one who knows. BUT the cash they will spend on keeping the stock price down - and hopefully getting partnership or buyout - pails in comparison for a potential $100b dollar market for Alzheimer’s..What we need are catalysts to move this stock higher, big players to take positions and in the end - if phase 3 data matches phase 2 - get a bidding war going between big Pharma..Regardless the journey will be like the bumpy, so keep your seatbelt on there’s going to be turbulence…
      1,808评论
      举报
      keep your seatbelt
    • T20211222001T20211222001
      ·2021-12-22
      $Amazon.com(AMZN)$ weekly chart so ugly from 3300 to 3400 back and forth no clear direction , I think it continues and we go back to 3300 then back to 3400 until we break above or downward.
      488评论
      举报
    • T20211222001T20211222001
      ·2021-12-22

      Watch for a squeeze

      $Reliance Global Group, Inc.(RELI)$ NEXT ONE TO DO THIS IS RMO. Now 32% short and $189m cash with $564m in backlog. Do the due diligence and wait to see it double first then ride to the expected $16 from the current $4. Nothing says you have to get it all. Watch for a squeeze.$Reliance Global Group, Inc.(RELI)$
      1,002评论
      举报
      Watch for a squeeze
    • T20211222001T20211222001
      ·2021-12-15
      $Palantir Technologies Inc.(PLTR)$ If Jerome doesn't say they are raising interest rates or start a taper tantrum, this is gonna explode back into the 20's easily (MACD is about to cross positive). Otherwise the entire market is going to take a dump. For some reason I feel like this is what everyone is expecting, and after 2018's taper tantrum I don't think they are going to do it again so quickly.
      1,7631
      举报
    • T20211222001T20211222001
      ·2021-12-15
      $Nu Holdings Ltd.(NU)$ IPO 1-2-3 pullback setup, today should be interesting. Could run up to new highs.
      940评论
      举报
    • T20211222001T20211222001
      ·2021-11-25

      above $6 next week!

      $Progenity, Inc.(PROG)$ People thinking this’ll dip any further are heavily mistaken. Lowest point from here will be 3.50 if anything on Friday. Monday we will begin green and Tuesday being a settlement date will cause this to rocket the rest of the week after that. End of next week we’ll be near or above $6. Either way, There in heavy control of this one,athyrium or whoever, accumulating shares, all I can say is I'm not missing it.
      1,021评论
      举报
      above $6 next week!
    • T20211222001T20211222001
      ·2021-11-15

      Just buy and hold!

      $Altamira Therapeutics Ltd.(CYTO)$ Wow, after performing DD this stock is so undervalued. Upcoming catalysts:1. AM-125 Phase 2 Completion (expected to close Dec 1, 2021) and data readout a month later (expected 1st week 2022, if not then Q1, 2022).2. DCGI nod on go ahead to conduct Bentrio trials in India. In-vitro efficacy against covid 19 and delta variant already established from previous PRs.3. Sales number indications from six south east markets and 3-4 european markets. (expected to be around 5-10 millions ?).4. Start of study around RNA therapeutics.5. 194 million volume from last session, tons of shorting I assume.6. Shorts hedging by putting money on 19 Nov calls 2.5, 5 and 7.5. I expect some action due to that.Please add if I have missed an
      9201
      举报
      Just buy and hold!
       
       
       
       

      热议股票